Are you a ‘leader’ or a ‘follower’? This study will disclose that

Monash Institute of Cognitive and Clinical Neurosciences conducted a study using functional magnetic resonance imaging to investigate what parts of the brains become active when people disagree with others. There is a general tendency in our society to nod your head in agreement even if you do not actually agree and this habit of agreeing is generally used to avoid confrontational or unpleasant situations in one’s life.

great-leader

But, did you know this very habit of yours about agreeing or not agreeing can indicate what kind of a person you are? Brain scans found that those who rarely disagree have a different brain structure than those who do. According to the researchers, these areas of the brain are also linked to other life implications such as poor decision making, anxiety or interpersonal relationship problems, researchers say.

Dr Pascal Molenberghs, senior author of the study said: “People like to agree with others, a social default known as the truth bias, which is helpful in forming and maintaining social relationships. The study involved 39 right-handed participants who were given 192 true or false statements about four topics, viz. Biology, history, medical and physics. Each topic had 24 true and 24 false statements that were attributed to an individual with high or low expertise in the area – a professor or a student. The participants were then asked to decide which statements were true and which were false. They were also told that each answer was checked for accuracy and that most were incorrect, which was done to make sure they would make an attempt to disagree.

When the results were checked, only half of the participants agreed more often with the statements. The results of the imaging scan showed that those who rarely disagree with others display activity in the medial prefrontal cortex and anterior insula when they actually do disagree. These areas of the brain are responsible for cognitive dissonance or heightened state of mental stress. The study explained: ‘Having a lot of trouble disagreeing due to a heightened cognitive dissonance response may be indicative of an array of emotional, attitudinal or social issues compromising an individual’s capacity to make autonomous choices.’

So now you know, leaders never feel scared to disagree with others. They believe in putting their point across, whereas followers tend to be a ‘yes-man’ to avoid any kind of conflict and this can further lead to sadness and depression and mental stress. Now that you know, the ball is in your court. Take your life where you want to take it!

[adinserter block=”7″]

Author: Technology and Beyond

Immortality? This Experiment Might Provide a Breakthrough!

Senescence is the condition of cells of the body starting to age. A senescent cells doesn’t only die, but also starts to pump out a brew of compounds that can cause damage to surrounding tissue. The process, called senescence, is thought to protect us against cancer and help wounds heal.

BG7P49 Scientist watching mice in laboratory. Image shot 2009. Exact date unknown.

But as we get older, senescent cells start to accumulate across the body, and may be partly responsible for the general wear and tear of all our organs as we age. Elevated numbers of these cells have already been linked to heart failure, arthritis, Alzheimer’s – and cancer.

Darren Baker, Jan van Deursen and their colleagues at the Mayo Clinic in Rochester, Minnesota, conducted various studies on mice, and have been successful in wiping out senescent cells. They did so by tagging the senescent cells with a “suicide gene”, which on activation triggers the death of 70 percent of the tagged cells.

Baker is working with Unity Biotechnology, which launched last week, and bills itself as the first company to develop medicines that specifically target senescence. One of its founders is Judith Campisi of the Buck Institute for Research on Aging in Novato, California, who pioneered work on senescence.

The team used this method to wipe out senescent cells from mice that were 12 months old – about 40 in human years – twice a week, for the rest of their lives. It is around this age that the accumulation of senescent cells is thought to start causing problems. “This can be thought of as a prevention strategy, because we never let the cells accumulate,” says Baker.

The treated mice lived, on average, around 25 per cent longer than their untreated counterparts. “That’s the equivalent of extending human life from 80 to 100 years,” says Baker. Not only that, improvement was seen in their heart conditions and their ability to handle stress after 6 months of treatment. What’s more, the treated mice were able to stave off age-related disease. Their kidneys showed less of the scarring usually seen with ageing. They didn’t develop cataracts or cancer until much later in life, compared with untreated mice. They even looked younger, because they didn’t show the same fat loss as untreated mice.

A similar study by Baker and his colleagues in 2011, showed when they used the same technique to slow the ageing of mice with a disorder that makes them age more quickly.

“If you had asked me about this in 2011, I would have said we were a long way off,” says Baker. “But we’ve been working with a company to find drugs that kill senescent cells, and it’s easier than we thought.”

Campisi hopes to treat age-related conditions as preventable and curable, rather than treating symptoms of diseases where the end is inevitable and debilitating. “It is extraordinarily rewarding to see our discoveries move toward clinical trials.”

The ultimate aim is to develop a drug that could hit all age-related diseases in one go.

[adinserter block=”7″]

Author: Technology and Beyond

Verified by ExactMetrics